Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
AstraZeneca (United Kingdom) · GlaxoSmithKline (United Kingdom) · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
740
total citations
- FWCI
- 20.39
- Percentile
- 100%
- References
- 105
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Profiling (computer programming)
- Drug discovery
- Drug
- Medicine
- Pharmaceutical industry
- Drug development
- New drug application
- Pharmacology
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.